Sebastian Gaede, smartpatient CEO and founder
February 14, 2022 02:02 PM ESTUpdated 05:19 PM
Pharma
Marketing

Mo­bile app de­vel­op­er adds dis­ease-spe­cif­ic mod­ules for pa­tients – and phar­ma part­ners

Beth Snyder Bulik

Senior Editor

While phar­ma com­pa­nies have strug­gled to gain trac­tion with mo­bile apps for pa­tients, one de­vel­op­er is work­ing on a way to help. Smart­pa­tient is launch­ing …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump names Johns Hop­kins re­searcher Mar­ty Makary to lead the FDA; al­so names CDC, Sur­geon Gen­er­al picks

FDA ap­proves Bridge­Bio's heart dis­ease drug, set­ting up com­pe­ti­tion with Pfiz­er, Al­ny­lam

Drug or bi­o­log­ic? An Eli Lil­ly law­suit could im­pact weight loss drug com­pounders

Sur­round­ed by AI bio gi­ants, tiny start­up Nabla Bio makes de no­vo an­ti­bod­ies look more like drugs 

Pa­tient dies in Neu­ro­gene's Rett syn­drome study

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times